Brief: Bioarctic Receives Patent In Japan

BioArctic AB

23/08/2023 09:53

Aug 23 (Reuters) - BioArctic AB  BIOAb.ST :
    * RECEIVES PATENT IN JAPAN FOR NEW ANTIBODIES TARGETING
PARKINSON'S DISEASE
    * ANNOUNCED TODAY THAT JAPANESE PATENT OFFICE (JPO) IS
GRANTING
NEW DRUG SUBSTANCE PATENT FOR ANTIBODY BAN0805, INVENTED BY
BIOARCTIC AS POTENTIAL TREATMENT OF PARKINSON'S DISEASE
    * PATENT WILL EXPIRE IN 2041, WITH POSSIBILITY OF A PATENT
TERM
EXTENSION UP UNTIL 2046

Source text for Eikon:  ID:nWkrkQVzZ 
Further company coverage:  BIOAb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))